These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
409 related articles for article (PubMed ID: 21364924)
1. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. Hedlund M; Nagaeva O; Kargl D; Baranov V; Mincheva-Nilsson L PLoS One; 2011 Feb; 6(2):e16899. PubMed ID: 21364924 [TBL] [Abstract][Full Text] [Related]
2. Generation of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications. Chitadze G; Bhat J; Lettau M; Janssen O; Kabelitz D Scand J Immunol; 2013 Aug; 78(2):120-9. PubMed ID: 23679194 [TBL] [Abstract][Full Text] [Related]
3. Cancer exosomes and NKG2D receptor-ligand interactions: impairing NKG2D-mediated cytotoxicity and anti-tumour immune surveillance. Mincheva-Nilsson L; Baranov V Semin Cancer Biol; 2014 Oct; 28():24-30. PubMed ID: 24602822 [TBL] [Abstract][Full Text] [Related]
4. Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: mechanism of immune evasion. Lundholm M; Schröder M; Nagaeva O; Baranov V; Widmark A; Mincheva-Nilsson L; Wikström P PLoS One; 2014; 9(9):e108925. PubMed ID: 25268476 [TBL] [Abstract][Full Text] [Related]
5. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells. Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909 [TBL] [Abstract][Full Text] [Related]
6. Differential expression of ligands for NKG2D and DNAM-1 receptors by epithelial ovarian cancer-derived exosomes and its influence on NK cell cytotoxicity. Labani-Motlagh A; Israelsson P; Ottander U; Lundin E; Nagaev I; Nagaeva O; Dehlin E; Baranov V; Mincheva-Nilsson L Tumour Biol; 2016 Apr; 37(4):5455-66. PubMed ID: 26563374 [TBL] [Abstract][Full Text] [Related]
7. [Effects of matrine on the expression of NKG2D ligands in leukemia cells]. Ma LD; Lu XZ; Zhu ZC; Jiang LJ; Zhou M; Qian SX; Li JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1429-34. PubMed ID: 24370024 [TBL] [Abstract][Full Text] [Related]
8. Endometriotic Tissue-derived Exosomes Downregulate NKG2D-mediated Cytotoxicity and Promote Apoptosis: Mechanisms for Survival of Ectopic Endometrial Tissue in Endometriosis. Björk E; Israelsson P; Nagaev I; Nagaeva O; Lundin E; Ottander U; Mincheva-Nilsson L J Immunol; 2024 Sep; 213(5):567-576. PubMed ID: 38984872 [TBL] [Abstract][Full Text] [Related]
9. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications. Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211 [TBL] [Abstract][Full Text] [Related]
10. The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition. Chaouat AE; Seliger B; Mandelboim O; Schmiedel D Front Immunol; 2021; 12():714799. PubMed ID: 34721381 [TBL] [Abstract][Full Text] [Related]
11. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. Hedlund M; Stenqvist AC; Nagaeva O; Kjellberg L; Wulff M; Baranov V; Mincheva-Nilsson L J Immunol; 2009 Jul; 183(1):340-51. PubMed ID: 19542445 [TBL] [Abstract][Full Text] [Related]
12. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma. Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A Front Immunol; 2018; 9():1282. PubMed ID: 29963042 [TBL] [Abstract][Full Text] [Related]
13. NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8 Vadstrup K; Galsgaard ED; Jensen H; Lanier LL; Ryan JC; Chen SY; Nolan GP; Vester-Andersen MK; Pedersen JS; Gerwien J; Jensen T; Bendtsen F Exp Mol Pathol; 2017 Aug; 103(1):56-70. PubMed ID: 28684217 [TBL] [Abstract][Full Text] [Related]
14. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma. Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of NKG2D ligands in acute lymphoblastic leukemia and non-Hodgkin lymphoma cells by romidepsin and enhanced in vitro and in vivo natural killer cell cytotoxicity. Satwani P; Bavishi S; Saha A; Zhao F; Ayello J; van de Ven C; Chu Y; Cairo MS Cytotherapy; 2014 Oct; 16(10):1431-40. PubMed ID: 24856896 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells. Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914 [TBL] [Abstract][Full Text] [Related]
17. [Matrine enhances the cytotoxic sensitivity of ABCG2high nasopharyngeal carcinoma cells to natural killer cells by inducing high expression of NKG2D receptor ligands]. Huang YX; Wang Y; Sun M; Zhou XY; Deng L; Guo KY Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jul; 29(7):1329-32. PubMed ID: 19620045 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms. Fujita H; Hatanaka Y; Sutoh Y; Suzuki Y; Oba K; Hatanaka KC; Mitsuhashi T; Otsuka N; Fugo K; Kasahara M; Matsuno Y J Histochem Cytochem; 2015 Mar; 63(3):217-27. PubMed ID: 25473094 [TBL] [Abstract][Full Text] [Related]